Search Results Page
Search Results
1 - 8 of 8 (0.35 seconds)Section 37 in The Finance Act, 2018 [Entire Act]
The Commissioner Of Income-Tax vs M/S Kap Scan & Diagnostic Centre Pvt. Ltd on 3 December, 2010
Another strong
reference has been made to the decision of Hon'ble Punjab & Haryana High Court in the case of
CIT vs. Kap Scan and Diagnostic Centre (P.) Ltd. [2012] 25 taxmann.com 92, wherein
commission was paid to the private doctors for referring the patients for diagnosis to the assessee
company. In background of these facts and issues involved, the Hon'ble High Court held that said
payment of commission is wrong and is opposed to be a public policy. It should be discouraged as
it is not a fair practice. The ratio of said decision cannot be applied on the facts of the present case
because there is no violation of any law or anything which is opposed to public policy.
Eskayef Now Known As Smithkline Beecham ... vs Commissioner Of Income Tax ... on 20 July, 2000
Similarly,
there is reference to the decision of Hon'ble Supreme Court in the case of Eskayef (Now Known
as Smithkline Beecham) Pharmaceuticals (India) Limited v. CIT (2000) 111 Taxman 561(SC),
which was given in context of Section 37(3A) of the Act. In the said case the assessee had
claimed expenditure on distribution of physician's samples u/s. 37. In the background of such
claim the Hon'ble Apex court held that, if the expenditure falls within the bare minimum it will
not be caught by subsection (3A) of section 37. On the contrary, the Hon'ble Apex Court
observed that physicians samples are necessary to ascertain the efficacy of medicine and
introduce it in the market for circulation and it is only by this method the purpose is achieved. In
such cases giving a physician samples for reasonable period is essential to the business of
manufacture and sale of medicine. It is only if a particular medicine has been introduced by the
market and its uses are established then giving of free samples could only be the measure of sale/
promotion and development would thus be hit by subsection (3A). Said decision no way prohibits
the nature of expenditure which has been incurred in the case of the assessee. Therefore, such a
9
2880/Mum/16.Bayer.
Section 7 in The Finance Act, 2018 [Entire Act]
Max Hospital, Pitampura vs Medical Council Of India on 10 January, 2014
We find that issue of applicability of MCI guideline and Board Circular had been deliberated
upon by the Hon'ble Delhi High Court in the case of Max Hospital Pitampura vs. Medical
Council of India(Writ Petition No.1334 of 2013, dtd.10/01/2014).We would like to reproduce
the judgment of the Hon'ble Delhi High Court and same reads as under :
The Finance Act, 2018
Radha Swami Satsang vs Income-Tax Officer on 26 April, 1982
In our considered
view, principles of Res judicata is not applicable to income tax proceedings although we are fully
agreeable that principles of consistency is to be maintained (Hon'ble Supreme Court decision in
Radha Soami Satsang v. CIT (1992) 193 ITR 321 (SC) but in the instant AY., we have observed
that these overseas trips for Doctors and their spouses were organized by the assessee whereby no
details of the contents of seminar, if any conducted by the assessee overseas has been brought on
record and also even the spouses accompanied the Doctors to the overseas trip which included
cruise visit to island, gala dinners, cocktail, gala entertainment etc. rather than being directed
towards seminar for product information dissemination or directed towards knowledge
enhancement or knowledge sharing oriented as no details of seminar and its course content is
brought on record rather the trip is directed towards leisure and entertainment of Doctors and their
spouses which in our view appears to be clearly a distinguishable feature in this year enabling us
to take a divergent view and the expenses incurred by the assessee cannot be allowed as business
expenditure u/s. 37 of the Act as it is clearly hit by explanation to Section 37 of the Act being
against public policy as unethical prohibited by law. In view of the above, he pointed out that in
the above decision for A.Y. 2009-10 in the case of Liva Healthcare, there was a specific finding
8
2880/Mum/16.Bayer.
1